Harnessing technology transferred from VTT Technical Research Centre of Finland, Proteins.1 is developing a PCR-like ...

An innovative gene-editing strategy could establish a new way for the body to manufacture therapeutic proteins—including ...

Takara Bio USA, Inc. today announced the launch of its CSP Program and announced the certification of Admera Health on the ...

In 2011, The Scientist featured Bergmann’s early work on stomata development. She now uses new omics tools to explore the ...

As we age, our cells accumulate genetic changes—mutations—some of which open the door to cancer. Scientists call these ...

Cell-based assay innovation is reshaping how we discover, validate, and de-risk therapeutic candidates across disease areas. This Research Topic invites ...

This important study advances a new computational approach to measure and visualize gene expression specificity across different tissues and cell types. The framework is potentially helpful for ...

AWS Social Impact and Sustainability Program awards Admera Health, Bringing Next-Generation Genomics to Underserved ...

MGI Tech marks a decade of progress in genomics, highlighting key technology milestones that have accelerated life science ...

Inflammation research sits at the intersection of immunology, systems biology, and molecular medicine, focusing on the cellular and molecular mechanisms ...

Researchers from The University of Texas MD Anderson Cancer Center will present breakthrough studies at the American Association for Cancer Research (AACR) Annual Meeting 2026.

MGI Tech Co., Ltd. (MGI), a company dedicated to developing core tools and technologies that drive innovation in life sciences, celebrates its 10th anniversary, a decade marked by breakthroughs that ...